facebookrssdk flag

RESEARCH

NIKKB RESEARCH UNIT

Towards 2022, NIKKB research will focus on developing customised treatment for the individual patient, research into how we can implement new knowledge in daily practice and understand the lifelong trajectory of musculoskeletal disease.

Focus

NIKKB'S RESEARCH STRATEGY 2018-2022

The Research Unit at NIKKB has formulated a strategy outlining the institute's research priorities for the period 2018-2022.

Download it here

Research

The strategic aim of the research efforts at NIKKB is to continue to contribute new knowledge in the musculoskeletal field by focusing on solving specific challenges at the level of both the patient and society, specifically:

 

  • Patients with musculoskeletal problems experience different clinical courses, which is why we will continue our work to establish ‘customised’ interventions based on new knowledge.
  • Our ambition is to focus on implementation research where new knowledge about the barriers to, and methods for, promoting the systematic application of research findings is further developed and embedded in daily clinical practice.
  • At NIKKB, our research has always sought to understand the life trajectories of musculoskeletal disease. This will still apply. We will continue to study these clinical courses in order to develop insights that are useful and practical in prevention and treatment.

 

Research focus

To meet these strategic priorities, the following research areas will be the principal focus up to the end of 2022:

 

  1. Patient profiles & differentiated care
  2. Implementation research & knowledge translation
  3. Musculoskeletal heath from a life course perspective with a special focus on spinal health

 

Read more about our research focus under the section Project Areas in the menu.

 

_______________________________________________________________________________________________

News

9th Interdisciplinary World Congress on Low Back and Pelvic Girdle Pain

 

Take part in the 9th Interdisciplinary World Congress on Low Back and Pelvic Girdle Pain in Singapore in 2016 and update your knowledge of lumbar and pelvic pain.

 

Professor and Head of Research at the IOB and Senior Researcher at NIKKB, Jan Hartvigsen, is a member of the organizing committee and a speaker at the 9th Interdisciplinary World Congress on Low Back and Pelvic Girdle Pain in Singapore from 31 October to 3 November 2016. Jan Hartvigsen was also invited to speak at the congress, when it…

Read more

Traffic collisions may have long-term consequences in terms of damage to the neck and back, the so-called Whiplash Associated Disorders. A Danish study published in the European Journal of Pain shows that the healing of this kind of damage can be about much more than the damage itself.

 

The term Whiplash Associated Disorders (WAD) reflects the fact that many injured complain about other symptoms besides whiplash after a traffic collision. It may be pain in other parts of the spine, tingling and tingling in the arms or legs, fatigue, nausea, cognitive problems, poor physical and mental health, depression and…

Read more

NIKKB researcher wins top prize in Athens

Alice Kongsted, senior researcher at NIKKB and lecturer at the IOB, was awarded first prize in WFC’s Research Poster Award Competition for the best poster presentation at the WFC / ECU's World Congress 13 - 16-May in Athens.

 

Alice Kongsted presented two posters at the Congress, and received the prize for her poster entitled "Are chiropractic patients afraid of movement? - You can easily find out if your patient are " where she and two graduate students have studied the simplest and easiest way to screen chiropractic patients for fear of movement.

 

The award is a great accolade…

Read more

An examination of data from a number of publications demonstrates a slight increase in the risk of cardiovascular problems by the use of high doses of ibuprofen, writes Dagens Medicin on its website dagensmedicin.dk.

 

Ibuprofen is a pain reliever and anti-inflammatory drug, which is given to patients with joint pain among others, but according to a review of available data by the European Medicines Agency (EMA) adverse effects committee PRAC, a dose of 2400 mg or more per day may increase the risk of cardiovascular problems such as heart attack and stroke.

 

PRAC recommends that the advice…

Read more

Researchers in Sweden have identified four simple living rules that can reduce the risk of back pain considerably: Drop cigarettes, drink moderate amounts of alcohol, get regular exercise and be sure to get a daily intake of fruits and vegetables.

 

An extensive research experiment at the Karolinska Institute in Stockholm is the first to demonstrate the link between a healthy lifestyle and lifestyle diseases. The research experiment was conducted in the form of a public survey of 9000 men and women in Stockholm County, and the results are remarkable: Among the women who followed the four living rules, 9…

Read more